mplexity originates and develops biotech companies that target medical breakthroughs. > Develops concepts around molecular assets or target diseases > Manages interests (usually ≥10% equity) in the resultant companies > Therapeutic areas: CNS, cardiovascular/metabolic, oncology, liver disease > Focus on de-risked assets or new mechanisms; sometimes both > Built around a core team of five managers with >100 years of collective industry experience
| Website | https://www.mplexity.com/ |
| Employees | 1 (0 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Biotech Startups, Drug Discovery, Medical Breakthroughs, Therapeutic Development, New Drug Development, Pharmaceutical Development, Biotech Incubator, Early Stage Biotech, Clinical Development, Biotechnology Investment, Life Sciences Investment, Cns Therapeutics, Pharmaceutical Investment, Biotech Portfolio, Health Tech Investment, Portfolio Management |
Looking for a particular mplexity employee's phone or email?